Table 3.
Cox univariate and multivariate analysis of prognostic parameters for OS and PFS of patients with clear cell RCC (n = 69)
| Prognostic parameter | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | |
| Overall survival | ||||||
| Stage (I, II vs III, IV) | 5.474 | 1.198–25.010 | 0.028 | 3.062 | 0.579–16.190 | 0.188 |
| Grade (1, 2 vs 3) | 3.002 | 0.796–11.330 | 0.105 | 1.565 | 0.354–6.929 | 0.555 |
| CD8 (low vs high) | 2.278 | 0.685–7.573 | 0.179 | |||
| Foxp3 (low vs high) | 1.437 | 0.460–4.495 | 0.533 | |||
| PD-L1 (low vs high) | 4.418 | 1.374–14.210 | 0.013 | 2.122 | 0.538–8.366 | 0.282 |
| PD-L2 (low vs high) | 1.664 | 0.501–5.527 | 0.406 | |||
| B7-H4 (low vs high) | 1.637 | 0.519–5.162 | 0.400 | |||
| Galectin-9 (low vs high) | 4.043 | 1.283–12.740 | 0.017 | 3.330 | 0.921–12.040 | 0.067 |
| Progression-free survival | ||||||
| Stage (I, II vs III, IV) | 12.450 | 3.744–41.420 | < 0.001 | 9.987 | 2.881–34.610 | < 0.001 |
| Grade (1, 2 vs 3) | 4.194 | 1.727–10.190 | 0.002 | 2.155 | 0.835–5.564 | 0.113 |
| CD8 (low vs high) | 1.444 | 0.686–3.038 | 0.333 | |||
| Foxp3 (low vs high) | 1.052 | 0.489–2.265 | 0.896 | |||
| PD-L1 (low vs high) | 1.968 | 0.787–4.921 | 0.148 | |||
| PD-L2 (low vs high) | 1.234 | 0.520–2.926 | 0.634 | |||
| B7-H4 (low vs high) | 2.248 | 1.025–4.932 | 0.043 | 2.227 | 0.982–5.050 | 0.055 |
| Galectin-9 (low vs high) | 1.471 | 0.658–3.287 | 0.347 | |||
HR hazard ratio, CI confidence interval